BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15117040)

  • 1. Comparison of topical lomefloxacin 0.3 per cent versus topical ciprofloxacin 0.3 per cent for the treatment of presumed bacterial corneal ulcers.
    Booranapong W; Kosrirukvongs P; Prabhasawat P; Srivannaboon S; Suttiprakarn P
    J Med Assoc Thai; 2004 Mar; 87(3):246-54. PubMed ID: 15117040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of ophthalmic lomefloxacin 0.3% in comparison with fortified cefazolin and gentamicin ophthalmic solutions in the treatment of presumed bacterial keratitis.
    Erjongmanee S; Kasetsuwan N; Phusitphoykai N; Puangsricharern V; Pariyakanok L
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S83-90. PubMed ID: 16083168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical ciprofloxacin for bacterial corneal ulcer.
    Kosrirukvongs P; Buranapongs W
    J Med Assoc Thai; 2000 Jul; 83(7):776-82. PubMed ID: 10932513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
    Hyndiuk RA; Eiferman RA; Caldwell DR; Rosenwasser GO; Santos CI; Katz HR; Badrinath SS; Reddy MK; Adenis JP; Klauss V
    Ophthalmology; 1996 Nov; 103(11):1854-62; discussion 1862-3. PubMed ID: 8942881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis.
    Parmar P; Salman A; Kalavathy CM; Kaliamurthy J; Prasanth DA; Thomas PA; Jesudasan CA
    Am J Ophthalmol; 2006 Feb; 141(2):282-286. PubMed ID: 16458681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
    Constantinou M; Daniell M; Snibson GR; Vu HT; Taylor HR
    Ophthalmology; 2007 Sep; 114(9):1622-9. PubMed ID: 17822972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies on topical lomefloxacin and ciprofloxacin on ocular kinetic and experimental corneal ulcer.
    Velpandian T; Gupta SK; Gupta YK; Agarwal HC; Biswas NR
    J Ocul Pharmacol Ther; 1999 Dec; 15(6):505-11. PubMed ID: 10609773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative lomefloxacin 0.3% prophylaxis in strabismus surgery.
    Snir M; Hasanreisoglu M; Friling R; Goldenberg-Cohen N; Ehrlich R; Bagan J; Axer-Siegel R
    Curr Eye Res; 2008 Oct; 33(10):819-25. PubMed ID: 18853315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of the white precipitate formed on the corneal surface after treatment with ciprofloxacin ophthalmic solution.
    Madhavan HN; Rao SK; Joseph PR; Sulochana KN
    Cornea; 1999 Sep; 18(5):549-52. PubMed ID: 10487428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
    Rahman A; Rizwan S; Waycaster C; Wall GM
    Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa.
    Roland PS; Pien FD; Schultz CC; Henry DC; Conroy PJ; Wall GM; Garadi R; Dupre SJ; Potts SL; Hogg LG; Stroman DW;
    Curr Med Res Opin; 2004 Aug; 20(8):1175-83. PubMed ID: 15324520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single topical agent is clinically equivalent to the combination of topical and oral antibiotic treatment for otitis externa.
    Roland PS; Belcher BP; Bettis R; Makabale RL; Conroy PJ; Wall GM; Dupre S; Potts S; Hogg G; Weber K;
    Am J Otolaryngol; 2008; 29(4):255-61. PubMed ID: 18598837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of topical fixed-combination fortified vancomycin-amikacin (VA solution) to conventional separate therapy in the treatment of bacterial corneal ulcer.
    Chiang CC; Lin JM; Chen WL; Chiu YT; Tsai YY
    Eye (Lond); 2009 Feb; 23(2):294-8. PubMed ID: 18188174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical cure of bacterial conjunctivitis with azithromycin 1%: vehicle-controlled, double-masked clinical trial.
    Abelson MB; Heller W; Shapiro AM; Si E; Hsu P; Bowman LM;
    Am J Ophthalmol; 2008 Jun; 145(6):959-65. PubMed ID: 18374301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lomefloxacin is an effective treatment of experimental bacterial keratitis.
    Kowalski RP; Romanowski EG; Yates KA; Gordon YJ
    Cornea; 2001 Apr; 20(3):306-8. PubMed ID: 11322421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of two chondroitin sulfate ophthalmic solutions in the therapy of spontaneous chronic corneal epithelial defects and ulcerative keratitis associated with bullous keratopathy in dogs.
    Ledbetter EC; Munger RJ; Ring RD; Scarlett JM
    Vet Ophthalmol; 2006; 9(2):77-87. PubMed ID: 16497231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits.
    Jensen H; Zerouala C; Carrier M; Short B
    J Ocul Pharmacol Ther; 2005 Feb; 21(1):36-43. PubMed ID: 15718826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream.
    Lipsky BA; Holroyd KJ; Zasloff M
    Clin Infect Dis; 2008 Dec; 47(12):1537-45. PubMed ID: 18990064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
    Panda A; Ahuja R; Sastry SS
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():744-7. PubMed ID: 10707137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes.
    Roland PS; Anon JB; Moe RD; Conroy PJ; Wall GM; Dupre SJ; Krueger KA; Potts S; Hogg G; Stroman DW
    Laryngoscope; 2003 Dec; 113(12):2116-22. PubMed ID: 14660913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.